Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene

International Journal of Cancer

Volumn 80, Issue 6, 1999, Pages 823-826

  Rio, Pascale G ^a,b   Maurizis, Jean Claude ^b   Peffault De Latour, Monique ^a   Bignon, Yves Jean ^a   Bernard Gallon, Dominique J ^a  

^a CENTRE JEAN PERRIN   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ANALYTIC METHOD; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MARKER GENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ASSAY;

BRCA1 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, BRCA1; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033559967     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990315)80:6<823::AID-IJC5>3.0.CO;2-3     Document Type: Article

References (22)

1. BERNARD, D., MAURIZIS, J.-C., CHASSAGNE, J., CHOLLET, P. and PLAGNE, R., Comparison of class II HLA antigen expression in normal and carcinomatous human breast cells. Cancer Res., 45, 1152-1158 (1985).
2. BERNARD, D., MAURIZIS, J.-C., CHOLLET, P., CHASSAGNE, J. and PLAGNE, R., Isolation and purification of HLA-DR antigens from tumour cells by affinity chromatography and chromatofocusing. J. Chromatogr., 308, 322-328 (1984).
3. BERNARD-GALLON, D., CRESPIN, N., MAURIZIS, J.-C. and BIGNON, Y.-J., Cross-reaction between antibodies raised against the last 20 C-terminal amino acids of BRCA1 (C-20) and human EGF and EGF-R in MCF10a human mammary epithelial cell line. Int. J. Cancer, 71, 123-126 (1997).
4. CHEN, Y., CHEN, C.-F., RILEY, D.J., ALLRED, D.C., CHEN, P.-L., VON HOFF, D., OSBORNE, K. and LEE, W.-H., Aberrant subnuclear localization of BRCA1 in breast cancer. Science, 270, 789-791 (1995).
5. COHN, E., The chemical specificity of the interaction of diverse human plasma proteins. Blood, 3, 471-485 (1948).
6. CRESPIN, N., MAURIZIS, J.C., FERRARA, M., BOUGNOUX, P., RIO, P., BIGNON, Y.-J. and BERNARD-GALLON, D., Fatty acid-dependent or independent regulation of BRCAI in human breast cancer. Cancer Detect. Prevent., 20, 506-507 (1996).
7. DEFAZIO, A., CHIEW, Y.-E., MCEVOY, M., WATTS, C.K.W. and SUTHERLAND, R.L., Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells. Cell Growth Differentiation, 8, 903-911 (1997).
8. DUBROVIC, A. and SIMPFENDORFER, D., Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res., 57, 3347-3350 (1997).
9. FUTREAL, P.A. and 26 OTHERS, BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122 (1994).
10. KAINU, T., KONONEN, J., JOHANSSON, O., OLSSON, H., BORG, A. and ISOLA, J., Detection of germline BRCA1 mutations in breast-cancer patients by quantitative messenger RNA in situ hybridization. Cancer Res., 56, 2912-2915 (1996).
11. KOENDERS, P.G., BEEX, L.V.A.M., GEURTS-MOESPOT, A., HEUVEL, J.J.T.M., KIENHUIS, C.B.M. and BENRAAD, T.J., Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res., 51, 4544-4548 (1991).
12. MANCINI, D.N., RODENHISER, D.I., AINSWORTH, P.J., O'MALLEY, F.P., SINGH, S.M., XING, W. and ARCHER, T.K., CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene, 16, 1161-1169 (1998).
13. MARQUIS, S.T., RAJAN, J.V., WYNSHAW-BORIS, A., XU, J., YIN, G.Y., ABEL, K.J., WEBER, B.L. and CHODOSH, L.W., The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nature (Genet.), 11, 17-26 (1995).
14. MERAJVER, S.D., PHAM, T.M., CADUFF, R.F., CHEN, M., POY, E.L., COONEY, K.A., WEBER, B.L., COLLINS, F.S., JOHNSTON, C. and FRANK, T.S., Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature (Genet.), 9, 439-443 (1995).
15. MIKI, Y. and 44 OTHERS, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA-1. Science, 266, 66-71 (1994).
16. RIBIERAS, S., MAGDINIER, F., LECLERC, D., LENOIR, G., FRAPPART, L. and DANTE, R., Abundance of BRCA1 transcripts in human cancer and lymphoblastoid cell lines carrying BRCA1 germ-line alterations. Int. J. Cancer, 73, 715-718 (1997).
17. RIO, P.G., PERNIN, D., BAY, J.-O., ALBUISSON, E., KWIATKOWSKI, F., DE LATOUR, M., BERNARD-GALLON, D. and BIGNON, Y.-J., Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Int. J. Oncol., 13, 849-853 (1998).
18. TAYLOR, J., LYMBOURA, M., PACE, P.E., A'HERN, R.P., DESAI, A.J., SHOUSHA, S., COOMBES, R.C. and ALI, S., An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer, 79, 334-342 (1998).
19. THAKUR, S., ZHANG, H.B., PENG, Y., LE, H., CARROLL, B., WARD, T., YAO, J., FARID, L.M., COUCH, F.J., WILSON, R.B. and WEBER, B.L., Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. cell. Biol., 17, 444-452 (1997).
20. THOMPSON, M.E., JENSEN, R.A., OBERMILLER, P.S., PAGE, D.L. and HOLT, J.T., Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature (Genet.), 9, 444-450 (1995).
21. WILSON, C.A., PAYTON, M.N., ELLIOTT, G.S., BUAAS, F.W., CAJULIS, E.E., GROSSHANDS, D., RAMOS, L., REESE, D.M., SLAMON, D.J. and CALZONE, F.J., Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b. Oncogene. 14, 1-16 (1997).
22. WILSON, C.A., PAYTON, M.N., PEKAR, S.K., ZHANG, K., PACIFICI, E.E., GUDAS, J.L., THUKRAL, S., CALZONE, F.J., REESE, D.M. and SLAMON, D.I., BRCA1 protein products: antibody specificity. Nature (Genet.), 13, 264-265 (1996).